Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03389620 · ClinicalTrials.gov registry record · Phase 2
Transforaminal Versus Lateralized Interlaminar Cervical Epidurals
A Phase 2 study of Cervicogenic Upper Extremity Radiculopathy, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT03389620: Completed Phase 2 study of Cervicogenic Upper Extremity Radiculopathy, sponsored by Duke University.
NCT03389620 is a Phase 2 study of Cervicogenic Upper Extremity Radiculopathy that has completed, run by Duke University. The registered enrollment target is 74 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03389620, a Phase 2 study of Cervicogenic Upper Extremity Radiculopathy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two methods of giving epidural steroid injections for nerve pain in the arm that comes from the neck. An epidural steroid injection can be given in two different ways, either in the back of the spine within the neck or in the neck next to the nerve root going to the arm. Both are standard medical treatments. The investigators would like to see how effective these treatments are, and if there are any differences in effectiveness or safety between these two routes.
Primary Outcome
The pain numerical rating scale (NRS) is a well-validated tool for quantitatively assessing patients' pain. The NRS asks patients to rate their current pain intensity on an 11-point scale ranging from 0 ("no pain") to 10 ("worst possible pain")
Conditions Studied
Interventions
- DRUG dexamethasone
Study Locations (1)
North Carolina
- Duke Radiology and Orthopaedic Clinic - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2023-09-16 |
| Phase | Phase 2 |
What the finished NCT03389620 record still lists
NCT03389620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Cervicogenic Upper Extremity Radiculopathy appearing as the primary indexed condition, and to 1 intervention - of which dexamethasone is the first listed.
NCT03389620 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03389620 about?
NCT03389620 is a clinical study titled "Transforaminal Versus Lateralized Interlaminar Cervical Epidurals". The purpose of this study is to compare two methods of giving epidural steroid injections for nerve pain in the arm that comes from the neck. An epidural steroid injection can be given in two different ways, either in the back of the spine within the neck or in the neck next to the nerve root going ...
What is the current status of trial NCT03389620?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2018-01-05. Estimated completion is 2023-09-16.
What conditions does trial NCT03389620 study?
This clinical trial studies the following conditions: Cervicogenic Upper Extremity Radiculopathy.
What interventions are being tested in trial NCT03389620?
The interventions under investigation include: dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03389620?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03389620 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03389620's enrollment target sits among peer trials
74 920th of 2000 higher than 1,077 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI